跳至主要内容
临床试验/CTRI/2021/05/033356
CTRI/2021/05/033356尚未招募4 期

A comparison of efficacy and safety of topiramate and amitriptyline Vs amitriptyline alone in chronic migraine : A randomized controlled trial.

Principal Investigator Prof Jayantee Kalita0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • patients with chronic migraine attending neurology service will be included
  • diagnosis of chronic migraine will be based on ICHD-3 beta criteria (2013)-
  • adults >18 to <55 years of age
  • h/o at least 8 attacks of migraine (with or without aura )per month in last 3 months
  • h/o >15 headache days per month for >3 months
  • history of migraine (with or without aura)for >12 months prior to enrollment

排除标准

  • patients with uncontrolled diabeties/hypertension ,heart diseases,psychiatric disease,seizures,hearing deficit,ear disease,visual deficit,stroke like illness,infection,organ failure,malignancy,asthamatics,immunosuppressant,systemic disease,age <18 or >55 years ,migraine onset after 50 years of age ,on prophylactic treatment in past one month ,abortive medication with opioid drugs,pregnancy,and unwilling for consent

研究者

发起方
Principal Investigator Prof Jayantee Kalita

相似试验